A study has shown that the brand name medications Actos and Januvia were prescribed in over a quarter of doctor’s visits. These drugs are markedly more expensive than the recommended first-line generic medication metformin.
It’s no wonder than spending on diabetes drugs has doubled to $12.5 billion over the past 6 years. Unless there’s a medical contrindication, doctors shouldn’t be reaching for these brand name medications first.
